Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation.
In a 34-year-old patient toxoplasma retinitis/encephalitis developed 9 months after bone marrow transplantation. The BMT was complicated with a serious GVHD. Although she initially responded well to antibiotic therapy she died 2 years after BMT due to progressive infection.
Brinkman
K
K
Department of Internal Medicine, University Hospital, Nijmegen, The Netherlands.
Debast
S
S
Sauerwein
R
R
Ooyman
F
F
Hiel
J
J
Raemaekers
J
J
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D002981:Clindamycin / Q000627:therapeutic use; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D016781:Toxoplasmosis, Cerebral / Q000188:drug therapy / Q000209:etiology*; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy / Q000209:etiology*
D000890:Anti-Infective Agents; D007166:Immunosuppressive Agents; D013411:Sulfadiazine; D002981:Clindamycin; D011739:Pyrimethamine